Galapagos NV reports results for the quarter ended March 31 - Earnings Summary

• Galapagos NV GLPG.AS reported a quarterly adjusted loss of €2.33​​ per share for the quarter ended March 31, lower than the same quarter last year, when the company reported EPS of €1.37. The mean expectation of two analysts for the quarter was for a loss of 19 cents per share. Wall Street expected results to range from -30 cents to -9 cents per share.

• Revenue rose 20.1% to €74.98 million from a year ago; analysts expected €70.44 million.

• Galapagos NV's reported EPS for the quarter was a loss of €2.33​.

• The company reported a quarterly loss of €153.4 million.

FORECAST CHANGES

• In the last 30 days, there have been no earnings estimate revisions by analysts covering the company.

RECOMMENDATIONS

• The current average analyst rating on the shares is "hold" and the breakdown of recommendations is 1 "strong buy" or "buy," 7 "hold" and 3 "sell" or "strong sell." The average consensus recommendation for the biotechnology & medical research peer group is also "hold"

• Wall Street's median 12-month price target for Galapagos NV is €29.00

This summary was machine generated from LSEG data April 23 at 09:46 p.m. UTC. ​All figures in euros unless otherwise stated. (For questions concerning the data in this report, contact Estimates.Support@lseg.com. For any other questions or feedback, contact RefinitivNewsSupport@thomsonreuters.com)